Ordinance
on Clinical Trials
with the exception of
Clinical Trials of Medical Devices1
(Clinical Trials Ordinance, ClinO)

of 20 September 2013 (Status as of 26 May 2022)

1 Amended by Annex 2 No 2 of the O of 1 July 2020 on Clinical Trials with Medical Devices, in force since 26 May 2021 (AS 2020 3033).


Open article in different language:  DE  |  FR  |  IT
Art. 64 Approved registries and data to be entered

1 For an au­thor­ised clin­ic­al tri­al, the spon­sor must re­gister the data spe­cified in An­nex 5 num­ber 1:

a.
in a primary re­gistry47 re­cog­nised by the World Health Or­gan­iz­a­tion (WHO); or
b.
in the re­gistry of the U.S. Na­tion­al Lib­rary of Medi­cine48.

2 The spon­sor shall ad­di­tion­ally enter the data spe­cified in An­nex 5 num­ber 2 in the sup­ple­ment­ary fed­er­al data­base, us­ing a Swiss na­tion­al lan­guage.

3 The data must be entered in the form au­thor­ised by the re­spons­ible eth­ics com­mit­tee.

47 The re­gis­tries can be con­sul­ted at: www.who.int > Pro­grammes and pro­jects > Clin­ic­al Tri­als – In­ter­na­tion­al Re­gistry Plat­form.

48 The re­gistry can be con­sul­ted at: www.clin­ic­al­tri­als.gov

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden